February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
November 1, 2019 | Press Releases Validant Acquires DataRevive, a Regulatory Strategy and Consulting Business Focused on Novel Therapeutics and Biologics Carla Nieser 2 Minute Read
October 25, 2019 | Compliance SPF Labeled Products are Drugs in the USA. Is Your Company Compliant Under FDA Regulations? John McShane Managing Partner, Validant 2 Minute Read
June 16, 2019 | Compliance EU MDR Applicable to Drug Delivery Systems Brian Burns CEO, Validant 1 Minute Read
June 2, 2019 | Press Releases Validant Sponsors MedTech Summit EU MDR & IVDR: June 17-21 Carla Nieser 2 Second Read
February 16, 2019 | Compliance Outsourcing GxP Audits – Mindful Execution is Key to Success Barbara Unger Principal Consultant 4 Minute Read